Literature DB >> 19177015

Replication stress activates DNA polymerase alpha-associated Chk1.

Lorena Taricani1, Frances Shanahan, David Parry.   

Abstract

Chk1 contributes to both intra-S and DNA damage checkpoint responses. Here, we show that depletion of DNA Polalpha and not Polepsilon or Poldelta by siRNA induces phosphorylation of Chk1 on Ser345, thus phenocopying antimetabolite exposure. Combinatorial ablation of DNA Polalpha and Chk1 causes an accumulation of gamma-H2A.X, a marker of double-strand DNA breaks, suggesting that activation of Chk1 in this context is essential for suppression of DNA damage. Co-depletion of DNA Polalpha with ATR yields similar phenotypes, suggesting that ATR and Chk1 are epistatic and required for maintenance of genomic integrity following replication stress. Significantly, Chk1 and DNA Polalpha can be co-immunoprecipated from native cell extracts. Moreover, following replication stress, Polalpha-associated Chk1 becomes rapidly phosphorylated on Ser345 in a TopBP1 and ATR-dependent manner. Hence, the ability to efficiently phosphorylate Chk1 in the context of DNA Polalpha complexes is correlated with suppression of DNA damage following replication stress. These findings identify DNA Polalpha as an important component of the signal transduction cascade that activates the intra-S checkpoint.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177015     DOI: 10.4161/cc.8.3.7661

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Regulation of the Cell Cycle and Inflammatory Arthritis by the Transcription Cofactor LBH Gene.

Authors:  Shinji Matsuda; Deepa Hammaker; Katharyn Topolewski; Karoline J Briegel; David L Boyle; Steven Dowdy; Wei Wang; Gary S Firestein
Journal:  J Immunol       Date:  2017-08-14       Impact factor: 5.422

2.  Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Authors:  Amélie Fradet-Turcotte; Fanny Bergeron-Labrecque; Cary A Moody; Michaël Lehoux; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 3.  Translesion DNA Synthesis in Cancer: Molecular Mechanisms and Therapeutic Opportunities.

Authors:  Maroof K Zafar; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2017-09-28       Impact factor: 3.739

4.  Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

Authors:  Ryan Montano; Injae Chung; Kristen M Garner; David Parry; Alan Eastman
Journal:  Mol Cancer Ther       Date:  2011-12-27       Impact factor: 6.261

5.  Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation.

Authors:  Xiangzi Han; Franklin Mayca Pozo; Jacob N Wisotsky; Benlian Wang; James W Jacobberger; Youwei Zhang
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

Review 6.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

7.  CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells.

Authors:  Rebecca F Rogers; Michael I Walton; Daniel L Cherry; Ian Collins; Paul A Clarke; Michelle D Garrett; Paul Workman
Journal:  Cancer Res       Date:  2020-03-11       Impact factor: 12.701

8.  Tight Chk1 Levels Control Replication Cluster Activation in Xenopus.

Authors:  Marie Platel; Arach Goldar; Jennifer M Wiggins; Pedro Barbosa; Pierre Libeau; Pierre Priam; Hemalatha Narassimprakash; Xenia Grodzenski; Kathrin Marheineke
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo.

Authors:  Ryan Montano; Ruth Thompson; Injae Chung; Huagang Hou; Nadeem Khan; Alan Eastman
Journal:  BMC Cancer       Date:  2013-12-21       Impact factor: 4.430

10.  A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.

Authors:  Lorena Taricani; Frances Shanahan; Maria-Christina Malinao; Maribel Beaumont; David Parry
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.